Blood Glucose Control

Can a therapy improve metabolic health even if the scale does not budge? This question is becoming increasingly relevant as clinicians observe patients benefiting from GLP-1 therapy even without significant weight loss. While weight reduction has long been a primary goal of incretin-based therapies, emerging data suggest that metabolic improvements …

Managing hyperglycemia in oncology patients is becoming a critical part of cancer care, especially as newer therapies affect glucose metabolism. Have you ever wondered why patients with no history of diabetes suddenly develop high blood sugar during treatment? This growing challenge highlights the need for structured, practical approaches. In this …

When diabetes metric discordance shows up in clinical practice, it can feel like trying to read three clocks that all tell different times. A1C suggests one story, continuous glucose monitoring points to another, and patient symptoms may not match either. So how should clinicians respond when these signals conflict? Understanding …

Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …

The clinical use of time in range is changing how clinicians approach diabetes management. Instead of focusing only on A1C, many providers now rely on continuous glucose monitoring data to guide daily decisions. But how do you translate numbers into action? Think of it like a GPS for glucose control. …

Why does clinical inertia diabetes continue to slow progress, even when better treatments are widely available? It is a bit like having a high-performance car but hesitating to press the accelerator. Despite major advances in medications and care models, delays in intensifying therapy remain common. As a result, many patients …

Interest in diabetes remission is growing in 2026, but is it realistic for everyone? As research evolves, clinicians are rethinking how and when to pursue remission as a treatment goal. While the idea of reversing type 2 diabetes is appealing, not every patient will benefit equally. This article explores the …

Diabetes care can feel like navigating a maze of medications, glucose targets, and lifestyle changes. So how do clinicians ensure patients stay engaged for the long term? Shared decision making in diabetes care offers a practical answer by turning clinical conversations into collaborative partnerships. Instead of simply prescribing treatment, providers …

Early onset type 2 diabetes is no longer rare, and its rise among younger adults raises serious concerns. What happens when a chronic condition that typically appears later in life begins decades earlier? Much like starting a marathon with added weight, younger patients face a longer disease course and a …

Have you ever wondered why the same meal can spike one person’s blood sugar but barely affect another’s? Research into precision nutrition for diabetes is helping answer that question. For years, dietary advice for diabetes followed a general template. However, growing evidence shows that individual responses to food vary widely. …